Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-02-09Nutritional Therapy and Education With a Multimedia Application in the Metabolic Control of Patients With Type 2 Diabetes. Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2016-02-09Sonias Combination Tablets LD Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
-
CLINICAL_TRIALS study record update · 2016-02-04The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of Glucose-dependent Insulinotropic Polypeptide (GIP) in Patients With Type 2 Diabetes is Not Caused by Rapid Tachyphylaxis
-
CLINICAL_TRIALS study record update · 2016-02-02ClinicalTrials.gov study NCT02285205
-
CLINICAL_TRIALS study record update · 2016-01-27Impact of Nurse Case Management on Diabetes-related Health Outcomes in a Specialty Care Setting: A Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-01-21Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
-
CLINICAL_TRIALS study record update · 2016-01-20Patient Transfer Program for Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder
-
CLINICAL_TRIALS study record update · 2016-01-06Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Type 2 Diabetes Mellitus to Evaluate Weight Reduction, Glycemic Control, Safety, and Tolerability
-
CLINICAL_TRIALS study record update · 2015-12-30Does the DPP4 Inhibitor Sitagliptin Have a Role in Preventing Type 2 Diabetes- A Randomised Controlled Study.
-
CLINICAL_TRIALS study record update · 2015-12-16Effect of Low Glycemic Index Diets on Glucose Control in Non-Insulin Dependent Diabetics
-
CLINICAL_TRIALS study record update · 2015-12-15Effect of a Single Dose of the DPP-4 Inhibitor on Islet Function After Igestion of a Standardized Mixed Meal in Subjects With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2015-12-15Effect of Lixisenatide on Glucagon Secretion During Hypoglycemia in Patients With Insulin-treated Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2015-12-09A Phase IV, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Effect of 12-week Treatment With the Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Liraglutide or Dipeptidyl Peptidase-4 Inhibitor (DPP-4i) Sitagliptin on the Cardiovascular, Renal and Gastrointestinal System in Insulin-naïve Patients With Type 2 Diabetes (T2DM).
-
CLINICAL_TRIALS study record update · 2015-12-08Effect of Low Glycemic Index Diets (With Pulses) on Glucose Control in Non-Insulin Dependent Diabetics
-
CLINICAL_TRIALS study record update · 2015-12-08Effect of Low Glycemic Index Diets (With Canola Oil) on Glucose Control in Non-Insulin Dependent Diabetics
-
CLINICAL_TRIALS study record update · 2015-12-04Mechanisms of Type 2 Diabetes Improvement, Besides Weightloss After Gastric Bypass
-
CLINICAL_TRIALS study record update · 2015-12-03Increasing Skeletal Muscle Carnitine Content to Improve Glycaemic Control in Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2015-12-03Developing and Testing Accessible Web-based Support for Patient Self-management of Diabetes
-
CLINICAL_TRIALS study record update · 2015-12-03Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2015-12-02Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Addendum to: A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release to Those of Sitagliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin (Study BCB106)
-
CLINICAL_TRIALS study record update · 2015-12-02Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food
-
CLINICAL_TRIALS study record update · 2015-12-02Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide
-
CLINICAL_TRIALS study record update · 2015-12-02Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session.
-
CLINICAL_TRIALS study record update · 2015-11-26Optimization of SMBG Employing Modal Day Analysis: Examining Clinical Decision-making Processes Using Blinded FreeStyle Navigator Continuous Glucose Monitoring System (CGM)
-
CLINICAL_TRIALS study record update · 2015-11-25Drug Interaction Study of Henagliflozin and Retagliptin in Healthy Subjects